98
BUILDING A FOUNDATION OF IMMUNITY PRESENTED BY ELIAS KASS, ND

BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

Embed Size (px)

Citation preview

Page 1: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

BUILDING A FOUNDATION OF IMMUNITYPRESENTED BY ELIAS KASS ND

DISCLOSURES

This activity is jointly provided by Cardea and the Washington Department of Health

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Institute for Medical QualityCalifornia Medical Association (IMQCMA) through the joint providership of Cardea and the Washington Department of Health Cardea is accredited by the IMQCMA to provide continuing medical education for physicians

Cardea designates this webinar for a maximum of 1 AMA PRA category 1 credit(s)TM Physicians should claim credit commensurate with the extent of their participation in the activity

DISCLOSURES AND OBTAINING CONTINUING MEDICAL EDUCATION CREDIT

bull Successful completion of this continuing education activity includes the following

bull Attending the entire CE activity

bull Completing the online evaluation

bull At the end of the evaluation there are links to request the CME certificate

If you have any questions about this CE activity please contact Trang Kuss at trangkussdohwagov

The planners and presenters of this activity have no relevant financial relationships with any commercial interest pertaining to this activity

The following off label use will be discussed

bull Tdap vaccine (Adacel Boostrix)

CONFLICT OF INTEREST

BACKGROUND

bull Former software engineer graduated from the University of Michigan

bull Bastyr 2010 in Naturopathic Medicine and Midwifery

bull Away training in Vanuatu

bull Dual practice midwifery and naturopathic primary care 2010-2014

bull Now specializing in pediatric primary care and specialty infant feeding (breastfeeding tongue tie)

bull CDC Childhood Immunization Champion for Washington State in 2017

VACCINES ARE NATUROPATHIC

bull When we prevent disease we donrsquot need to treat

bull Vaccines reduce use of antibiotics and antibiotic resistance

bull Vaccines prevent misery suffering and death

WE STILL NEED VACCINES

bull Vaccine-preventable diseases still kill here and elsewhere

bull There are plenty of other diseases available to exercise the immune system

UNIVERSAL DISEASES

bull A universal disease affected nearly everyone at some point in their life

bull Measles mumps polio many others are universal

bull If a disease was universal how bad can it be Would Mother Nature really do something destructive

bull Yes

MEASLES A CASE STUDY

MORBIDITY VS MORTALITY

bull When the internet argues that the death rate was going down before vaccines that is true

bull But only because we developed treatments for the complications from measles

bull The case rate didnrsquot go down until the vaccine was introduced

MORTALITY VS CASES

Presenter
Presentation Notes
Left taken from httpnocompulsoryvaccinationcom20101012intellectual-dishonesty13Right CDC WSJ13

SIMPLE RASH

bull Measles complications in 40 of cases

bull Diarrhea

bull Middle ear infection

bull Bronchopneumonia

bull Encephalitis in 11000

bull Death in 21000 usually pneumonia or encephalitis

bull In developing countries up to 25 fatality rate

bull Subacute sclerosing panencephalitis (fatal) in 110000 or morebull Kids who get the measles before age 5 have a one in 1387 chance of developing SSPE (Wendorf et al 2016)

bull Kids who get the measles before age 1 have a one in 609 chance

Presenter
Presentation Notes
Cases fatality rate higher in those with vitamin A deficiency immunodeficiency

VACCINErsquoS CONTINUED CONTRIBUTION

bull Measles remains a leading cause of vaccine-preventable infant mortality but progress is being made

bull From 2000-2016

bull Reported measles incidence decreased 87 from 145 to 19 cases per million persons

bull Annual estimated measles deaths decreased 84 (204 million deaths prevented)

MMWR Oct 27 2017 Vol 66 No 42

PROS AND CONS OF NATURAL INFECTION

bull Immunity from natural infection often lasts longer (though this is questionable)

bull But in order to get that immunity you need to experience the disease

bull Suffering

bull Transmission to others

bull Complications

bull Death

bull Long term complications of measles include

bull SSPE (fatal)

bull Immunosuppression increasing deaths from other infectious diseases

bull More severe COPD in smokers who experienced measles

IMMUNOSUPPRESSION

bull After measles infection immunologic memory is suppressed for 2-3 years which increases all-cause mortality

bull Measles BCG and polio immunization reduced all-cause mortality rate by roughly half

Mina MJ Measles immune suppression and vaccination direct and indirect nonspecific vaccine benefits J Infect 201774 Suppl 1S10ndash7

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 2: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

DISCLOSURES

This activity is jointly provided by Cardea and the Washington Department of Health

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Institute for Medical QualityCalifornia Medical Association (IMQCMA) through the joint providership of Cardea and the Washington Department of Health Cardea is accredited by the IMQCMA to provide continuing medical education for physicians

Cardea designates this webinar for a maximum of 1 AMA PRA category 1 credit(s)TM Physicians should claim credit commensurate with the extent of their participation in the activity

DISCLOSURES AND OBTAINING CONTINUING MEDICAL EDUCATION CREDIT

bull Successful completion of this continuing education activity includes the following

bull Attending the entire CE activity

bull Completing the online evaluation

bull At the end of the evaluation there are links to request the CME certificate

If you have any questions about this CE activity please contact Trang Kuss at trangkussdohwagov

The planners and presenters of this activity have no relevant financial relationships with any commercial interest pertaining to this activity

The following off label use will be discussed

bull Tdap vaccine (Adacel Boostrix)

CONFLICT OF INTEREST

BACKGROUND

bull Former software engineer graduated from the University of Michigan

bull Bastyr 2010 in Naturopathic Medicine and Midwifery

bull Away training in Vanuatu

bull Dual practice midwifery and naturopathic primary care 2010-2014

bull Now specializing in pediatric primary care and specialty infant feeding (breastfeeding tongue tie)

bull CDC Childhood Immunization Champion for Washington State in 2017

VACCINES ARE NATUROPATHIC

bull When we prevent disease we donrsquot need to treat

bull Vaccines reduce use of antibiotics and antibiotic resistance

bull Vaccines prevent misery suffering and death

WE STILL NEED VACCINES

bull Vaccine-preventable diseases still kill here and elsewhere

bull There are plenty of other diseases available to exercise the immune system

UNIVERSAL DISEASES

bull A universal disease affected nearly everyone at some point in their life

bull Measles mumps polio many others are universal

bull If a disease was universal how bad can it be Would Mother Nature really do something destructive

bull Yes

MEASLES A CASE STUDY

MORBIDITY VS MORTALITY

bull When the internet argues that the death rate was going down before vaccines that is true

bull But only because we developed treatments for the complications from measles

bull The case rate didnrsquot go down until the vaccine was introduced

MORTALITY VS CASES

Presenter
Presentation Notes
Left taken from httpnocompulsoryvaccinationcom20101012intellectual-dishonesty13Right CDC WSJ13

SIMPLE RASH

bull Measles complications in 40 of cases

bull Diarrhea

bull Middle ear infection

bull Bronchopneumonia

bull Encephalitis in 11000

bull Death in 21000 usually pneumonia or encephalitis

bull In developing countries up to 25 fatality rate

bull Subacute sclerosing panencephalitis (fatal) in 110000 or morebull Kids who get the measles before age 5 have a one in 1387 chance of developing SSPE (Wendorf et al 2016)

bull Kids who get the measles before age 1 have a one in 609 chance

Presenter
Presentation Notes
Cases fatality rate higher in those with vitamin A deficiency immunodeficiency

VACCINErsquoS CONTINUED CONTRIBUTION

bull Measles remains a leading cause of vaccine-preventable infant mortality but progress is being made

bull From 2000-2016

bull Reported measles incidence decreased 87 from 145 to 19 cases per million persons

bull Annual estimated measles deaths decreased 84 (204 million deaths prevented)

MMWR Oct 27 2017 Vol 66 No 42

PROS AND CONS OF NATURAL INFECTION

bull Immunity from natural infection often lasts longer (though this is questionable)

bull But in order to get that immunity you need to experience the disease

bull Suffering

bull Transmission to others

bull Complications

bull Death

bull Long term complications of measles include

bull SSPE (fatal)

bull Immunosuppression increasing deaths from other infectious diseases

bull More severe COPD in smokers who experienced measles

IMMUNOSUPPRESSION

bull After measles infection immunologic memory is suppressed for 2-3 years which increases all-cause mortality

bull Measles BCG and polio immunization reduced all-cause mortality rate by roughly half

Mina MJ Measles immune suppression and vaccination direct and indirect nonspecific vaccine benefits J Infect 201774 Suppl 1S10ndash7

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 3: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

DISCLOSURES AND OBTAINING CONTINUING MEDICAL EDUCATION CREDIT

bull Successful completion of this continuing education activity includes the following

bull Attending the entire CE activity

bull Completing the online evaluation

bull At the end of the evaluation there are links to request the CME certificate

If you have any questions about this CE activity please contact Trang Kuss at trangkussdohwagov

The planners and presenters of this activity have no relevant financial relationships with any commercial interest pertaining to this activity

The following off label use will be discussed

bull Tdap vaccine (Adacel Boostrix)

CONFLICT OF INTEREST

BACKGROUND

bull Former software engineer graduated from the University of Michigan

bull Bastyr 2010 in Naturopathic Medicine and Midwifery

bull Away training in Vanuatu

bull Dual practice midwifery and naturopathic primary care 2010-2014

bull Now specializing in pediatric primary care and specialty infant feeding (breastfeeding tongue tie)

bull CDC Childhood Immunization Champion for Washington State in 2017

VACCINES ARE NATUROPATHIC

bull When we prevent disease we donrsquot need to treat

bull Vaccines reduce use of antibiotics and antibiotic resistance

bull Vaccines prevent misery suffering and death

WE STILL NEED VACCINES

bull Vaccine-preventable diseases still kill here and elsewhere

bull There are plenty of other diseases available to exercise the immune system

UNIVERSAL DISEASES

bull A universal disease affected nearly everyone at some point in their life

bull Measles mumps polio many others are universal

bull If a disease was universal how bad can it be Would Mother Nature really do something destructive

bull Yes

MEASLES A CASE STUDY

MORBIDITY VS MORTALITY

bull When the internet argues that the death rate was going down before vaccines that is true

bull But only because we developed treatments for the complications from measles

bull The case rate didnrsquot go down until the vaccine was introduced

MORTALITY VS CASES

Presenter
Presentation Notes
Left taken from httpnocompulsoryvaccinationcom20101012intellectual-dishonesty13Right CDC WSJ13

SIMPLE RASH

bull Measles complications in 40 of cases

bull Diarrhea

bull Middle ear infection

bull Bronchopneumonia

bull Encephalitis in 11000

bull Death in 21000 usually pneumonia or encephalitis

bull In developing countries up to 25 fatality rate

bull Subacute sclerosing panencephalitis (fatal) in 110000 or morebull Kids who get the measles before age 5 have a one in 1387 chance of developing SSPE (Wendorf et al 2016)

bull Kids who get the measles before age 1 have a one in 609 chance

Presenter
Presentation Notes
Cases fatality rate higher in those with vitamin A deficiency immunodeficiency

VACCINErsquoS CONTINUED CONTRIBUTION

bull Measles remains a leading cause of vaccine-preventable infant mortality but progress is being made

bull From 2000-2016

bull Reported measles incidence decreased 87 from 145 to 19 cases per million persons

bull Annual estimated measles deaths decreased 84 (204 million deaths prevented)

MMWR Oct 27 2017 Vol 66 No 42

PROS AND CONS OF NATURAL INFECTION

bull Immunity from natural infection often lasts longer (though this is questionable)

bull But in order to get that immunity you need to experience the disease

bull Suffering

bull Transmission to others

bull Complications

bull Death

bull Long term complications of measles include

bull SSPE (fatal)

bull Immunosuppression increasing deaths from other infectious diseases

bull More severe COPD in smokers who experienced measles

IMMUNOSUPPRESSION

bull After measles infection immunologic memory is suppressed for 2-3 years which increases all-cause mortality

bull Measles BCG and polio immunization reduced all-cause mortality rate by roughly half

Mina MJ Measles immune suppression and vaccination direct and indirect nonspecific vaccine benefits J Infect 201774 Suppl 1S10ndash7

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 4: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

The planners and presenters of this activity have no relevant financial relationships with any commercial interest pertaining to this activity

The following off label use will be discussed

bull Tdap vaccine (Adacel Boostrix)

CONFLICT OF INTEREST

BACKGROUND

bull Former software engineer graduated from the University of Michigan

bull Bastyr 2010 in Naturopathic Medicine and Midwifery

bull Away training in Vanuatu

bull Dual practice midwifery and naturopathic primary care 2010-2014

bull Now specializing in pediatric primary care and specialty infant feeding (breastfeeding tongue tie)

bull CDC Childhood Immunization Champion for Washington State in 2017

VACCINES ARE NATUROPATHIC

bull When we prevent disease we donrsquot need to treat

bull Vaccines reduce use of antibiotics and antibiotic resistance

bull Vaccines prevent misery suffering and death

WE STILL NEED VACCINES

bull Vaccine-preventable diseases still kill here and elsewhere

bull There are plenty of other diseases available to exercise the immune system

UNIVERSAL DISEASES

bull A universal disease affected nearly everyone at some point in their life

bull Measles mumps polio many others are universal

bull If a disease was universal how bad can it be Would Mother Nature really do something destructive

bull Yes

MEASLES A CASE STUDY

MORBIDITY VS MORTALITY

bull When the internet argues that the death rate was going down before vaccines that is true

bull But only because we developed treatments for the complications from measles

bull The case rate didnrsquot go down until the vaccine was introduced

MORTALITY VS CASES

Presenter
Presentation Notes
Left taken from httpnocompulsoryvaccinationcom20101012intellectual-dishonesty13Right CDC WSJ13

SIMPLE RASH

bull Measles complications in 40 of cases

bull Diarrhea

bull Middle ear infection

bull Bronchopneumonia

bull Encephalitis in 11000

bull Death in 21000 usually pneumonia or encephalitis

bull In developing countries up to 25 fatality rate

bull Subacute sclerosing panencephalitis (fatal) in 110000 or morebull Kids who get the measles before age 5 have a one in 1387 chance of developing SSPE (Wendorf et al 2016)

bull Kids who get the measles before age 1 have a one in 609 chance

Presenter
Presentation Notes
Cases fatality rate higher in those with vitamin A deficiency immunodeficiency

VACCINErsquoS CONTINUED CONTRIBUTION

bull Measles remains a leading cause of vaccine-preventable infant mortality but progress is being made

bull From 2000-2016

bull Reported measles incidence decreased 87 from 145 to 19 cases per million persons

bull Annual estimated measles deaths decreased 84 (204 million deaths prevented)

MMWR Oct 27 2017 Vol 66 No 42

PROS AND CONS OF NATURAL INFECTION

bull Immunity from natural infection often lasts longer (though this is questionable)

bull But in order to get that immunity you need to experience the disease

bull Suffering

bull Transmission to others

bull Complications

bull Death

bull Long term complications of measles include

bull SSPE (fatal)

bull Immunosuppression increasing deaths from other infectious diseases

bull More severe COPD in smokers who experienced measles

IMMUNOSUPPRESSION

bull After measles infection immunologic memory is suppressed for 2-3 years which increases all-cause mortality

bull Measles BCG and polio immunization reduced all-cause mortality rate by roughly half

Mina MJ Measles immune suppression and vaccination direct and indirect nonspecific vaccine benefits J Infect 201774 Suppl 1S10ndash7

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 5: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

BACKGROUND

bull Former software engineer graduated from the University of Michigan

bull Bastyr 2010 in Naturopathic Medicine and Midwifery

bull Away training in Vanuatu

bull Dual practice midwifery and naturopathic primary care 2010-2014

bull Now specializing in pediatric primary care and specialty infant feeding (breastfeeding tongue tie)

bull CDC Childhood Immunization Champion for Washington State in 2017

VACCINES ARE NATUROPATHIC

bull When we prevent disease we donrsquot need to treat

bull Vaccines reduce use of antibiotics and antibiotic resistance

bull Vaccines prevent misery suffering and death

WE STILL NEED VACCINES

bull Vaccine-preventable diseases still kill here and elsewhere

bull There are plenty of other diseases available to exercise the immune system

UNIVERSAL DISEASES

bull A universal disease affected nearly everyone at some point in their life

bull Measles mumps polio many others are universal

bull If a disease was universal how bad can it be Would Mother Nature really do something destructive

bull Yes

MEASLES A CASE STUDY

MORBIDITY VS MORTALITY

bull When the internet argues that the death rate was going down before vaccines that is true

bull But only because we developed treatments for the complications from measles

bull The case rate didnrsquot go down until the vaccine was introduced

MORTALITY VS CASES

Presenter
Presentation Notes
Left taken from httpnocompulsoryvaccinationcom20101012intellectual-dishonesty13Right CDC WSJ13

SIMPLE RASH

bull Measles complications in 40 of cases

bull Diarrhea

bull Middle ear infection

bull Bronchopneumonia

bull Encephalitis in 11000

bull Death in 21000 usually pneumonia or encephalitis

bull In developing countries up to 25 fatality rate

bull Subacute sclerosing panencephalitis (fatal) in 110000 or morebull Kids who get the measles before age 5 have a one in 1387 chance of developing SSPE (Wendorf et al 2016)

bull Kids who get the measles before age 1 have a one in 609 chance

Presenter
Presentation Notes
Cases fatality rate higher in those with vitamin A deficiency immunodeficiency

VACCINErsquoS CONTINUED CONTRIBUTION

bull Measles remains a leading cause of vaccine-preventable infant mortality but progress is being made

bull From 2000-2016

bull Reported measles incidence decreased 87 from 145 to 19 cases per million persons

bull Annual estimated measles deaths decreased 84 (204 million deaths prevented)

MMWR Oct 27 2017 Vol 66 No 42

PROS AND CONS OF NATURAL INFECTION

bull Immunity from natural infection often lasts longer (though this is questionable)

bull But in order to get that immunity you need to experience the disease

bull Suffering

bull Transmission to others

bull Complications

bull Death

bull Long term complications of measles include

bull SSPE (fatal)

bull Immunosuppression increasing deaths from other infectious diseases

bull More severe COPD in smokers who experienced measles

IMMUNOSUPPRESSION

bull After measles infection immunologic memory is suppressed for 2-3 years which increases all-cause mortality

bull Measles BCG and polio immunization reduced all-cause mortality rate by roughly half

Mina MJ Measles immune suppression and vaccination direct and indirect nonspecific vaccine benefits J Infect 201774 Suppl 1S10ndash7

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 6: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

VACCINES ARE NATUROPATHIC

bull When we prevent disease we donrsquot need to treat

bull Vaccines reduce use of antibiotics and antibiotic resistance

bull Vaccines prevent misery suffering and death

WE STILL NEED VACCINES

bull Vaccine-preventable diseases still kill here and elsewhere

bull There are plenty of other diseases available to exercise the immune system

UNIVERSAL DISEASES

bull A universal disease affected nearly everyone at some point in their life

bull Measles mumps polio many others are universal

bull If a disease was universal how bad can it be Would Mother Nature really do something destructive

bull Yes

MEASLES A CASE STUDY

MORBIDITY VS MORTALITY

bull When the internet argues that the death rate was going down before vaccines that is true

bull But only because we developed treatments for the complications from measles

bull The case rate didnrsquot go down until the vaccine was introduced

MORTALITY VS CASES

Presenter
Presentation Notes
Left taken from httpnocompulsoryvaccinationcom20101012intellectual-dishonesty13Right CDC WSJ13

SIMPLE RASH

bull Measles complications in 40 of cases

bull Diarrhea

bull Middle ear infection

bull Bronchopneumonia

bull Encephalitis in 11000

bull Death in 21000 usually pneumonia or encephalitis

bull In developing countries up to 25 fatality rate

bull Subacute sclerosing panencephalitis (fatal) in 110000 or morebull Kids who get the measles before age 5 have a one in 1387 chance of developing SSPE (Wendorf et al 2016)

bull Kids who get the measles before age 1 have a one in 609 chance

Presenter
Presentation Notes
Cases fatality rate higher in those with vitamin A deficiency immunodeficiency

VACCINErsquoS CONTINUED CONTRIBUTION

bull Measles remains a leading cause of vaccine-preventable infant mortality but progress is being made

bull From 2000-2016

bull Reported measles incidence decreased 87 from 145 to 19 cases per million persons

bull Annual estimated measles deaths decreased 84 (204 million deaths prevented)

MMWR Oct 27 2017 Vol 66 No 42

PROS AND CONS OF NATURAL INFECTION

bull Immunity from natural infection often lasts longer (though this is questionable)

bull But in order to get that immunity you need to experience the disease

bull Suffering

bull Transmission to others

bull Complications

bull Death

bull Long term complications of measles include

bull SSPE (fatal)

bull Immunosuppression increasing deaths from other infectious diseases

bull More severe COPD in smokers who experienced measles

IMMUNOSUPPRESSION

bull After measles infection immunologic memory is suppressed for 2-3 years which increases all-cause mortality

bull Measles BCG and polio immunization reduced all-cause mortality rate by roughly half

Mina MJ Measles immune suppression and vaccination direct and indirect nonspecific vaccine benefits J Infect 201774 Suppl 1S10ndash7

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 7: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

WE STILL NEED VACCINES

bull Vaccine-preventable diseases still kill here and elsewhere

bull There are plenty of other diseases available to exercise the immune system

UNIVERSAL DISEASES

bull A universal disease affected nearly everyone at some point in their life

bull Measles mumps polio many others are universal

bull If a disease was universal how bad can it be Would Mother Nature really do something destructive

bull Yes

MEASLES A CASE STUDY

MORBIDITY VS MORTALITY

bull When the internet argues that the death rate was going down before vaccines that is true

bull But only because we developed treatments for the complications from measles

bull The case rate didnrsquot go down until the vaccine was introduced

MORTALITY VS CASES

Presenter
Presentation Notes
Left taken from httpnocompulsoryvaccinationcom20101012intellectual-dishonesty13Right CDC WSJ13

SIMPLE RASH

bull Measles complications in 40 of cases

bull Diarrhea

bull Middle ear infection

bull Bronchopneumonia

bull Encephalitis in 11000

bull Death in 21000 usually pneumonia or encephalitis

bull In developing countries up to 25 fatality rate

bull Subacute sclerosing panencephalitis (fatal) in 110000 or morebull Kids who get the measles before age 5 have a one in 1387 chance of developing SSPE (Wendorf et al 2016)

bull Kids who get the measles before age 1 have a one in 609 chance

Presenter
Presentation Notes
Cases fatality rate higher in those with vitamin A deficiency immunodeficiency

VACCINErsquoS CONTINUED CONTRIBUTION

bull Measles remains a leading cause of vaccine-preventable infant mortality but progress is being made

bull From 2000-2016

bull Reported measles incidence decreased 87 from 145 to 19 cases per million persons

bull Annual estimated measles deaths decreased 84 (204 million deaths prevented)

MMWR Oct 27 2017 Vol 66 No 42

PROS AND CONS OF NATURAL INFECTION

bull Immunity from natural infection often lasts longer (though this is questionable)

bull But in order to get that immunity you need to experience the disease

bull Suffering

bull Transmission to others

bull Complications

bull Death

bull Long term complications of measles include

bull SSPE (fatal)

bull Immunosuppression increasing deaths from other infectious diseases

bull More severe COPD in smokers who experienced measles

IMMUNOSUPPRESSION

bull After measles infection immunologic memory is suppressed for 2-3 years which increases all-cause mortality

bull Measles BCG and polio immunization reduced all-cause mortality rate by roughly half

Mina MJ Measles immune suppression and vaccination direct and indirect nonspecific vaccine benefits J Infect 201774 Suppl 1S10ndash7

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 8: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

UNIVERSAL DISEASES

bull A universal disease affected nearly everyone at some point in their life

bull Measles mumps polio many others are universal

bull If a disease was universal how bad can it be Would Mother Nature really do something destructive

bull Yes

MEASLES A CASE STUDY

MORBIDITY VS MORTALITY

bull When the internet argues that the death rate was going down before vaccines that is true

bull But only because we developed treatments for the complications from measles

bull The case rate didnrsquot go down until the vaccine was introduced

MORTALITY VS CASES

Presenter
Presentation Notes
Left taken from httpnocompulsoryvaccinationcom20101012intellectual-dishonesty13Right CDC WSJ13

SIMPLE RASH

bull Measles complications in 40 of cases

bull Diarrhea

bull Middle ear infection

bull Bronchopneumonia

bull Encephalitis in 11000

bull Death in 21000 usually pneumonia or encephalitis

bull In developing countries up to 25 fatality rate

bull Subacute sclerosing panencephalitis (fatal) in 110000 or morebull Kids who get the measles before age 5 have a one in 1387 chance of developing SSPE (Wendorf et al 2016)

bull Kids who get the measles before age 1 have a one in 609 chance

Presenter
Presentation Notes
Cases fatality rate higher in those with vitamin A deficiency immunodeficiency

VACCINErsquoS CONTINUED CONTRIBUTION

bull Measles remains a leading cause of vaccine-preventable infant mortality but progress is being made

bull From 2000-2016

bull Reported measles incidence decreased 87 from 145 to 19 cases per million persons

bull Annual estimated measles deaths decreased 84 (204 million deaths prevented)

MMWR Oct 27 2017 Vol 66 No 42

PROS AND CONS OF NATURAL INFECTION

bull Immunity from natural infection often lasts longer (though this is questionable)

bull But in order to get that immunity you need to experience the disease

bull Suffering

bull Transmission to others

bull Complications

bull Death

bull Long term complications of measles include

bull SSPE (fatal)

bull Immunosuppression increasing deaths from other infectious diseases

bull More severe COPD in smokers who experienced measles

IMMUNOSUPPRESSION

bull After measles infection immunologic memory is suppressed for 2-3 years which increases all-cause mortality

bull Measles BCG and polio immunization reduced all-cause mortality rate by roughly half

Mina MJ Measles immune suppression and vaccination direct and indirect nonspecific vaccine benefits J Infect 201774 Suppl 1S10ndash7

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 9: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

MEASLES A CASE STUDY

MORBIDITY VS MORTALITY

bull When the internet argues that the death rate was going down before vaccines that is true

bull But only because we developed treatments for the complications from measles

bull The case rate didnrsquot go down until the vaccine was introduced

MORTALITY VS CASES

Presenter
Presentation Notes
Left taken from httpnocompulsoryvaccinationcom20101012intellectual-dishonesty13Right CDC WSJ13

SIMPLE RASH

bull Measles complications in 40 of cases

bull Diarrhea

bull Middle ear infection

bull Bronchopneumonia

bull Encephalitis in 11000

bull Death in 21000 usually pneumonia or encephalitis

bull In developing countries up to 25 fatality rate

bull Subacute sclerosing panencephalitis (fatal) in 110000 or morebull Kids who get the measles before age 5 have a one in 1387 chance of developing SSPE (Wendorf et al 2016)

bull Kids who get the measles before age 1 have a one in 609 chance

Presenter
Presentation Notes
Cases fatality rate higher in those with vitamin A deficiency immunodeficiency

VACCINErsquoS CONTINUED CONTRIBUTION

bull Measles remains a leading cause of vaccine-preventable infant mortality but progress is being made

bull From 2000-2016

bull Reported measles incidence decreased 87 from 145 to 19 cases per million persons

bull Annual estimated measles deaths decreased 84 (204 million deaths prevented)

MMWR Oct 27 2017 Vol 66 No 42

PROS AND CONS OF NATURAL INFECTION

bull Immunity from natural infection often lasts longer (though this is questionable)

bull But in order to get that immunity you need to experience the disease

bull Suffering

bull Transmission to others

bull Complications

bull Death

bull Long term complications of measles include

bull SSPE (fatal)

bull Immunosuppression increasing deaths from other infectious diseases

bull More severe COPD in smokers who experienced measles

IMMUNOSUPPRESSION

bull After measles infection immunologic memory is suppressed for 2-3 years which increases all-cause mortality

bull Measles BCG and polio immunization reduced all-cause mortality rate by roughly half

Mina MJ Measles immune suppression and vaccination direct and indirect nonspecific vaccine benefits J Infect 201774 Suppl 1S10ndash7

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 10: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

MORBIDITY VS MORTALITY

bull When the internet argues that the death rate was going down before vaccines that is true

bull But only because we developed treatments for the complications from measles

bull The case rate didnrsquot go down until the vaccine was introduced

MORTALITY VS CASES

Presenter
Presentation Notes
Left taken from httpnocompulsoryvaccinationcom20101012intellectual-dishonesty13Right CDC WSJ13

SIMPLE RASH

bull Measles complications in 40 of cases

bull Diarrhea

bull Middle ear infection

bull Bronchopneumonia

bull Encephalitis in 11000

bull Death in 21000 usually pneumonia or encephalitis

bull In developing countries up to 25 fatality rate

bull Subacute sclerosing panencephalitis (fatal) in 110000 or morebull Kids who get the measles before age 5 have a one in 1387 chance of developing SSPE (Wendorf et al 2016)

bull Kids who get the measles before age 1 have a one in 609 chance

Presenter
Presentation Notes
Cases fatality rate higher in those with vitamin A deficiency immunodeficiency

VACCINErsquoS CONTINUED CONTRIBUTION

bull Measles remains a leading cause of vaccine-preventable infant mortality but progress is being made

bull From 2000-2016

bull Reported measles incidence decreased 87 from 145 to 19 cases per million persons

bull Annual estimated measles deaths decreased 84 (204 million deaths prevented)

MMWR Oct 27 2017 Vol 66 No 42

PROS AND CONS OF NATURAL INFECTION

bull Immunity from natural infection often lasts longer (though this is questionable)

bull But in order to get that immunity you need to experience the disease

bull Suffering

bull Transmission to others

bull Complications

bull Death

bull Long term complications of measles include

bull SSPE (fatal)

bull Immunosuppression increasing deaths from other infectious diseases

bull More severe COPD in smokers who experienced measles

IMMUNOSUPPRESSION

bull After measles infection immunologic memory is suppressed for 2-3 years which increases all-cause mortality

bull Measles BCG and polio immunization reduced all-cause mortality rate by roughly half

Mina MJ Measles immune suppression and vaccination direct and indirect nonspecific vaccine benefits J Infect 201774 Suppl 1S10ndash7

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 11: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

MORTALITY VS CASES

Presenter
Presentation Notes
Left taken from httpnocompulsoryvaccinationcom20101012intellectual-dishonesty13Right CDC WSJ13

SIMPLE RASH

bull Measles complications in 40 of cases

bull Diarrhea

bull Middle ear infection

bull Bronchopneumonia

bull Encephalitis in 11000

bull Death in 21000 usually pneumonia or encephalitis

bull In developing countries up to 25 fatality rate

bull Subacute sclerosing panencephalitis (fatal) in 110000 or morebull Kids who get the measles before age 5 have a one in 1387 chance of developing SSPE (Wendorf et al 2016)

bull Kids who get the measles before age 1 have a one in 609 chance

Presenter
Presentation Notes
Cases fatality rate higher in those with vitamin A deficiency immunodeficiency

VACCINErsquoS CONTINUED CONTRIBUTION

bull Measles remains a leading cause of vaccine-preventable infant mortality but progress is being made

bull From 2000-2016

bull Reported measles incidence decreased 87 from 145 to 19 cases per million persons

bull Annual estimated measles deaths decreased 84 (204 million deaths prevented)

MMWR Oct 27 2017 Vol 66 No 42

PROS AND CONS OF NATURAL INFECTION

bull Immunity from natural infection often lasts longer (though this is questionable)

bull But in order to get that immunity you need to experience the disease

bull Suffering

bull Transmission to others

bull Complications

bull Death

bull Long term complications of measles include

bull SSPE (fatal)

bull Immunosuppression increasing deaths from other infectious diseases

bull More severe COPD in smokers who experienced measles

IMMUNOSUPPRESSION

bull After measles infection immunologic memory is suppressed for 2-3 years which increases all-cause mortality

bull Measles BCG and polio immunization reduced all-cause mortality rate by roughly half

Mina MJ Measles immune suppression and vaccination direct and indirect nonspecific vaccine benefits J Infect 201774 Suppl 1S10ndash7

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 12: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

SIMPLE RASH

bull Measles complications in 40 of cases

bull Diarrhea

bull Middle ear infection

bull Bronchopneumonia

bull Encephalitis in 11000

bull Death in 21000 usually pneumonia or encephalitis

bull In developing countries up to 25 fatality rate

bull Subacute sclerosing panencephalitis (fatal) in 110000 or morebull Kids who get the measles before age 5 have a one in 1387 chance of developing SSPE (Wendorf et al 2016)

bull Kids who get the measles before age 1 have a one in 609 chance

Presenter
Presentation Notes
Cases fatality rate higher in those with vitamin A deficiency immunodeficiency

VACCINErsquoS CONTINUED CONTRIBUTION

bull Measles remains a leading cause of vaccine-preventable infant mortality but progress is being made

bull From 2000-2016

bull Reported measles incidence decreased 87 from 145 to 19 cases per million persons

bull Annual estimated measles deaths decreased 84 (204 million deaths prevented)

MMWR Oct 27 2017 Vol 66 No 42

PROS AND CONS OF NATURAL INFECTION

bull Immunity from natural infection often lasts longer (though this is questionable)

bull But in order to get that immunity you need to experience the disease

bull Suffering

bull Transmission to others

bull Complications

bull Death

bull Long term complications of measles include

bull SSPE (fatal)

bull Immunosuppression increasing deaths from other infectious diseases

bull More severe COPD in smokers who experienced measles

IMMUNOSUPPRESSION

bull After measles infection immunologic memory is suppressed for 2-3 years which increases all-cause mortality

bull Measles BCG and polio immunization reduced all-cause mortality rate by roughly half

Mina MJ Measles immune suppression and vaccination direct and indirect nonspecific vaccine benefits J Infect 201774 Suppl 1S10ndash7

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 13: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

VACCINErsquoS CONTINUED CONTRIBUTION

bull Measles remains a leading cause of vaccine-preventable infant mortality but progress is being made

bull From 2000-2016

bull Reported measles incidence decreased 87 from 145 to 19 cases per million persons

bull Annual estimated measles deaths decreased 84 (204 million deaths prevented)

MMWR Oct 27 2017 Vol 66 No 42

PROS AND CONS OF NATURAL INFECTION

bull Immunity from natural infection often lasts longer (though this is questionable)

bull But in order to get that immunity you need to experience the disease

bull Suffering

bull Transmission to others

bull Complications

bull Death

bull Long term complications of measles include

bull SSPE (fatal)

bull Immunosuppression increasing deaths from other infectious diseases

bull More severe COPD in smokers who experienced measles

IMMUNOSUPPRESSION

bull After measles infection immunologic memory is suppressed for 2-3 years which increases all-cause mortality

bull Measles BCG and polio immunization reduced all-cause mortality rate by roughly half

Mina MJ Measles immune suppression and vaccination direct and indirect nonspecific vaccine benefits J Infect 201774 Suppl 1S10ndash7

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 14: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

PROS AND CONS OF NATURAL INFECTION

bull Immunity from natural infection often lasts longer (though this is questionable)

bull But in order to get that immunity you need to experience the disease

bull Suffering

bull Transmission to others

bull Complications

bull Death

bull Long term complications of measles include

bull SSPE (fatal)

bull Immunosuppression increasing deaths from other infectious diseases

bull More severe COPD in smokers who experienced measles

IMMUNOSUPPRESSION

bull After measles infection immunologic memory is suppressed for 2-3 years which increases all-cause mortality

bull Measles BCG and polio immunization reduced all-cause mortality rate by roughly half

Mina MJ Measles immune suppression and vaccination direct and indirect nonspecific vaccine benefits J Infect 201774 Suppl 1S10ndash7

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 15: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

IMMUNOSUPPRESSION

bull After measles infection immunologic memory is suppressed for 2-3 years which increases all-cause mortality

bull Measles BCG and polio immunization reduced all-cause mortality rate by roughly half

Mina MJ Measles immune suppression and vaccination direct and indirect nonspecific vaccine benefits J Infect 201774 Suppl 1S10ndash7

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 16: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

NON-SPECIFIC EFFECTS OF MEASLES AND OTHER VACCINES

1 Higgins JPT Soares-Weiser K Reingold A Systematic review of the non-specific effects of BCG DTP and measles containing vaccines httpwwwwhointimmunizationsagemeetings2014april (accessed 1 Jun 2014)

2 Strategic Advisory Group of Experts on Immunization Meeting of the Strategic Advisory Group of Experts on Immunization April 2014 - conclusions and recommendations Week Epidemiol Rec201489221ndash36 [PubMed]

3Aaby P Martins CL Garly ML et al Non-specific effects of standard measles vaccine at 45 and 9 months of age on childhood mortality randomised controlled trial BMJ 2010341c6495doi101136bmjc6495 [PMC free article] [PubMed]

4Aaby P Samb B Simondon F et al Non-specific beneficial effect of measles immunisation analysis of mortality studies from developing countries BMJ 1995311481ndash5 doi101136bmj3117003481[PMC free article] [PubMed]

5 Kristensen I Aaby P Jensen H Routine vaccinations and child survival follow up study in Guinea-Bissau West Africa BMJ 20003211435ndash8 doi101136bmj32172741435 [PMC free article] [PubMed]

6 Benn CS Netea MG Selin LK et alA small jabmdasha big effect non-specific immunomodulation by vaccinesTrends Immunol 201334431ndash9 doi101016jit201304004 [PubMed]

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 17: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

CONCERN TH1 VS TH2

bull Th1 cells decrease the production of IgE

bull Th2 cells increase the production of IgE

bull Babies are born with a predominance of Th2 a bias towards allergic responses

bull To reduce allergic responses stimulate Th1

bull Infection with bacteria and viruses stimulates production of Th1

bull Infection with worms and helminths stimulate production of Th2

bull If babieskids donrsquot experience infection will they develop more allergies

Presenter
Presentation Notes
httpsvaxopediaorg20171027myths-about-your-babys-immature-immune-system13httpmediachopedudatafilespdfsvaccine-education-center-vaccine-safety-engpdf

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 18: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

VACCINES DO NOT CAUSE ALLERGIES

bull Vaccines do not prevent all diseases

bull Babies and kids still experience lots of infections

bull Large well-controlled epidemiologic studies do not support the hypothesis that vaccines cause allergies

bull ldquoHigher cumulative vaccine antigen doses were associated with less allergic sensitization allergic disease and less severe infant eczemardquo

Offit PA Hackett CJ Addressing Parentsrsquo Concerns Do Vaccines Cause Allergic or Autoimmune Diseases Pediatrics 2003111(3)653ndash9

Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 19: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD
Presenter
Presentation Notes
Nilsson L Brockow K Alm J et al Vaccination and allergy EAACI position paper practical aspects Pediatric Allergy and Immunology 201728(7)628ndash4013

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 20: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

CONCERN VS ACTUAL EFFECT

bull There are many valid questions and concerns about vaccines

bull For the most part we have the data to answer these questions

bull Donrsquot stop at the question Keep going to the answer

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 21: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

MECHANISMPATHWAY VS ACTUAL EFFECT

bull Many concerns about vaccines are based on biochemical pathways or mechanism

bull Donrsquot stop there Just because something is possible or even plausible doesnrsquot mean it actually happens that way

bull Look at the clinical data and the large body of literature

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 22: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

CONCERN VARICELLA VS ZOSTER

Question Does varicella immunization increase the risk of shingles in the unvaccinated population because of lack of immune stimulationviral suppression

Answer No zoster rates were going up before varicella program and were not affected by varicella immunization (Hales 2013) (Siedler 2014)

Plus varicella immunization seems to reduce the risk of shingles in immunized people (Baxter 2013)

Presenter
Presentation Notes
Baxter R Ray P Tran TN et al Long-term Effectiveness of Varicella Vaccine A 14-Year Prospective Cohort Study Pediatrics 2013peds2012-330313Siedler A Dettmann M Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany Hum Vaccin Immunother 201410(12)3594ndash60013Hales CM Harpaz R Joesoef MR Bialek SR Examination of links between herpes zoster incidence and childhood varicella vaccination Ann Intern Med 2013159(11)739ndash451313

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 23: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

SAFETY MONITORING

bull Pre-licensure trials including phase I II and III

bull Post-licensure studies and surveillance

bull Vaccine Safety Datalink (VSD)

bull Vaccine Adverse Event Reporting System (VAERS)

bull Clinical Immunization Safety Assessment (CISA) project ndash investigation into possible events in specific people certain populations excluded by pre-licensure studies

bull httpswwwhistoryofvaccinesorgcontentarticlesvaccine-development-testing-and-regulation

bull httpswwwcdcgovvaccinesbasicstest-approvehtml

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 24: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

SAFETY MONITORING VAERS

bull Vaccine Adverse Event Reporting System

bull ldquoSpontaneous (passive) surveillance means that no active effort is made to search for identify and collect information but rather information is passively received from those who choose to voluntarily report their experiencerdquo (Shimabukuro 2015)

bull Anyone can file any report

bull All reports are reviewed

bull ldquo[VAERS] reporting is incomplete requires follow-up investigation and cannot directly distinguish temporal associations from causal associations Consequently VAERS functions as a hypothesis-generating mechanism an early-warning signal of potential problems regarding vaccine safetyrdquo (Schwartz 2012)

Shimabukuro TT Nguyen M Martin D DeStefano F Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 201533(36)4398ndash405Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 25: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

SAFETY MONITORING VACCINE SAFETY DATALINK (VSD)

bull Includes multiple large HMOsMCOs covering 88 million people in 2011

bull Huge numbers allow for detection of rareserious events

bull Objectives of the Vaccine Safety Datalinkbull To conduct research on important vaccine safety questions in large populations

bull To conduct vaccine safety studies that come from questions or concerns in the medical literature or from other vaccine safety systems like VAERS

bull To monitor possible adverse events when new vaccines are licensed or when there are new vaccine recommendations

bull To provide information to committees who make recommendations for the nation

httpswwwcdcgovvaccinesafetyensuringsafetymonitoringvsdindexhtml

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 26: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

VACCINE SAFETY CASE ROTAVIRUS

bull In 1999 based on reports of 15 infants (of 15 million doses administered) experiencing intussusception after immunization with Rotashield the CDC recommended suspending use temporarily while investigation proceeded

bull Researchers found statistically significant differences in RotaShield vaccination rates between the two groups hellip Based on these results and estimates of the background rate of intussusception among US infants the research team estimated one additional case of intussusception attributable to the vaccine for every 4670 to 9474 infants vaccinated

bull Wyeth pulled the vaccine from the market when it was clear ACIP would vote against its use

Side bar Interesting moral questions about ldquoslamming the doorrdquo on a rotavirus vaccine that stood to save many lives internationally where the risk benefit ratio might be different (Schwartz 2012)

Schwartz JL The First Rotavirus Vaccine and the Politics of Acceptable Risk Milbank Q 201290(2)278ndash310

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 27: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

VACCINE SAFETY CASE ROTAVIRUS

bull Rotateq (pentavalent) licensed in 2006

bull Rotarix (monovalent) licensed in 2008

bull Studies of the two new vaccines included 60000 to 70000 infants each in which no increased risk of intussusception was identified

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 28: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

VSD ROTAVIRUS (2014)

RESULTS

During the study period 207955 doses of monovalent rotavirus vaccine (including 115908 first doses and 92047 second doses) were administered in the VSD population We identified 6 cases of intussusception within 7 days after the administration of either dose of vaccine For the two doses combined the expected number of intussusception cases was 072 resulting in a significant relative risk of 84 For the pentavalent rotavirus vaccine 1301810 doses were administered duringthe study period with 8 observed intussusception cases (711 expected) for a nonsignificant relative risk of 11 The relativerisk of chart-confirmed intussusception within 7 days after monovalent rotavirus vaccination as compared with the risk after pentavalent rotavirus vaccination was 94 (95 confidence interval 14 to 1038) The attributable risk of intussusception after the administration of two doses of monovalent rotavirus vaccine was estimated to be 53 per 100000 infants vaccinated

Action

bull Rotavirus was pulled out of the multi-vaccine VIS

bull Rotavirus VIS was updated with specific information about the risks of rotavirus and clinical presentation

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 29: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

ROTAVIRUS WHY BOTHER

PRE-VACCINEbull Every year globally

bull 111 million episodes of gastroenteritis requiring only home care

bull 25 million outpatient medical visits

bull 2 million hospitalizations

bull 400000 deaths

POST-VACCINEbull A dramatic decrease (gt80) in the incidence of

severe rotavirus diarrhea has been reported in high-income countries

bull A decrease of about 50 has been reported in low-income settings

bull Reductions in diarrhea-associated deaths of 31 in infants younger than 1 year old and 42 in children younger than 5 years old in countries with low child mortality

OrsquoRyan M Rotavirus Vaccines a story of success with challenges ahead F1000 Research 20176 Parashar et al Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003 May9(5)565-72

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 30: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

EFFICACY CASE LAIV (FLUMIST)

bull ldquoIn light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013ndash14 and 2015ndash16 seasons for the 2016ndash17 season ACIP makes the interim recommendation that LAIV4 should not be usedrdquo

bull Even though it would cost the manufacturer as the ACIP recommendation drives usage and insurance coverage

Grohskopf LA Prevention and Control of Seasonal Influenza with Vaccines MMWR Recomm Rep 201665

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 31: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

WHO IS ACIP

bull The Advisory Committee on Immunization Practices ldquoincludes 15 voting members responsible for making vaccine recommendations The Secretary of the US Department of Health and Human Services (DHHS) selects these members following an application and nomination process Fourteen of the members have expertise in vaccinology immunology pediatrics internal medicine nursing family medicine virology public health infectious diseases andor preventive medicine one member is a consumer representative who provides perspectives on the social and community aspects of vaccination

bull In addition to the 15 voting members ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States and 30 non-voting representatives of liaison organizations that bring related immunization expertiserdquo

httpswwwcdcgovvaccinesacipabouthtml

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 32: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

ACIP - SCHEDULE

bull How do vaccines get added Do vaccines ever get taken offbull Work group convene to work on one vaccine-preventable disease or group of diseases

bull Work group members collect and review data on disease epidemiology vaccine efficacy effectiveness safety feasibility of program implementation and economic aspects of immunization policy to include in written policy statements

bull Insurance companies and Medicaid generally pay for whatrsquos on the ACIP schedule so these recommendations have financial repercussions

bull Because immunity is not inherited we need to immunize each persongeneration until the disease is truly eradicated

bull ACIP meetings are open to the public and can be viewed by streaming webcast

bull If recommendations are accepted by the CDC they are published in the MMWR

httpswwwcdcgovvaccinesacipabouthtml

Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 33: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 34: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

WALKING THROUGH THE CHILDHOOD SCHEDULE

bull Prevent what we can when it matters most

bull When a child is most likely to encounter a disease

bull And when they are most likely to experience complications

bull Develop immunity before encountering the disease

bull Building a strong foundation of immunity right from the start

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 35: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

TYPES OF VACCINES

bull Live attenuated -- retains the ability to replicate (grow) and produce immunity but usually does not cause illnessbull live attenuated viruses ndash eg MMR varicella

bull live attenuated bacteria ndash eg typhoid BCG

bull Inactivatedbull Whole bacteria ndash eg whole cell pertussis

bull Whole viruses ndash eg injected influenza vaccine

bull Fractionalbull protein-based --

bull toxoid (inactivated toxin) ndash eg tetanus

bull subunit or subvirion ndash eg the new shingles vaccine

bull recombinant ndash eg hep B

bull polysaccharide-based

bull pure cell wall polysaccharide from bacteria ndash eg PPSV23

bull Conjugate polysaccharide vaccines contain polysaccharide that is chemically linked to a protein ndash eg PCV

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 36: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

VACCINES PREVENT DISEASE

Presenter
Presentation Notes
Plain Talk about Childhood Immunization 2013

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 37: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

WHY SHOULD WE EVEN PREVENT DISEASE

bull Depending on when you were born you may say ldquoI had measles why shouldnrsquot theyrdquo or ldquoI had chicken pox why shouldnrsquot theyrdquo

bull Some people diebull This burden falls disproportionately on vulnerable populations

bull Others have serious long-lasting injury (what doesnrsquot kill you doesnrsquot always make you stronger)bull Invasive Hib can cause lasting hearing or brain damage

bull Polio can cause lasting paralysis

bull Meningococcal can cause limb loss

bull Even when we canrsquot prevent all cases we can reduce the risk of severe disease and serious complications

Presenter
Presentation Notes
httpswwwprincetonedunews20150507deadly-shadow-measles-may-weaken-immune-system-three-years13httpswwwncbinlmnihgovpmcarticlesPMC4823017
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 38: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD
Presenter
Presentation Notes
This version is mailed out as part of the Child Profile health promotions mailing program (WA DOH) fileCUsersEliasDropboxArticlesChicago15_ImmuGuide_E17Lpdf
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 39: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD
Presenter
Presentation Notes
httpswwwcdcgovvaccinesscheduleshcpimzchild-adolescenthtml

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 40: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

HEP B WHYldquoThis is a sexually transmitted

infection why is it given to newbornsrdquo

I get that this is a public health measure but my patients arenrsquot at risk

If the mom doesnrsquot have hep B there is no risk to her baby so baby doesnrsquot

need this vaccine

I donrsquot want to risk a vaccine side effect that might complicate the

newbornrsquos stay

This is given at birth because theyrsquore a captive audience and

itrsquos the only chance to immunize them

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 41: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

HEP B STARTS AT BIRTH

ldquoMy baby isnrsquot having sex or doing drugs why should they get this vaccinerdquo

350000000 people in the world have chronic hepatitis B

Most of them contracted the virus when they were kids

Older than 5 when infected -gt fewer than 5 go on to chronic disease

1mdash5 years old -gt 30

Under 1 -gt 90 go on to have chronic disease

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 42: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

THE POWER OF HEPATITIS B

bull Tenacity virus can survive dried out on a surface for a week+

bull Highly infectious up to 30 of people who encounter hepatitis B actually get the disease (compared to HIV at 003)

bull Chronic hepatitis B causes 50-60 of all liver cancer

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 43: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

PREVENTION

Immunizing only high risk infants didnrsquot work

1Immunizing high risk infants and adolescents didnrsquot work

2Immunizing all infants works

3

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 44: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

INFANTS DO HAVE IMMUNE SYSTEMS

bull Maybe not as powerful as it will eventually be but powerful enough to respond appropriately to vaccines

bull Universal hepatitis B vaccine for newborns has reduced acute hepatitis B infections by 94

bull Prevent acute cases and you prevent chronic cases

bull Prevent what we can when it matters most

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 45: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

ALUMINUM

Aluminum is ubiquitous in the earthrsquos crust

Aluminum salts have been used as adjuvants since the 1940s with lots of safety data

Adjuvants are needed to lsquoirritatersquo the immune system so it pays attention to the vaccine

Aluminum is cleared by the kidneys

Single doses of aluminum-containing vaccines are different than infants receiving aluminum-containing TPN around the clock

Presenter
Presentation Notes
httpsvaxplanationswordpresscom20140411is-the-aluminium-in-vaccines-a-dangerous-amount-is-it-toxic

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 46: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

ALUMINUM IN TPN

ldquoParenteral nutrition (PN) has long been implicated as a major source of aluminum exposure due to contamination of the component ingredients PN component products are contaminated with aluminum in raw materials as well as byproducts from the manufacturing process where aluminum leaches from glass vials during autoclaving [101112] Patients at greatest risk for aluminum toxicity from PN include those with underlying renal dysfunction and prolonged courses of PN therapy Premature infants are particularly at high risk of aluminum accumulation and toxicity as they often require PN for many days and have immature kidneys incapable of excreting aluminum efficiently Calcium gluconate and phosphate salts are known to be especially high in aluminum content and are often administered to premature infants in substantial amounts to promote bone mineralization [101314]rdquo

Poole RL Pieroni KP Gaskari S Dixon T Kerner JA Aluminum Exposure in Neonatal Patients Using the Least Contaminated Parenteral Nutrition Solution Products Nutrients 20124(11)1566ndash74

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 47: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

DOES ALUMINUM BIOACCUMULATE IS IT CORRELATED WITH DEVELOPMENTAL DISABILITYObjective To evaluate relationships between whole blood (B-Al) and hair aluminum (H-Al) levels in healthy infants and their immunizationhistory and development

Methods We conducted a cross-sectional study of 9- to 13-month-old children recruited from an urban primary care center excluding those with a history of renal disease or receipt of either aluminum-containing pharmaceuticals or parenteral nutrition Aluminum levels were measured using inductively coupled plasma-mass spectrometry Correlation with Bayley Scales of Infant and Toddler Development Third Edition (BSID) and vaccine-related aluminum load was assessed via linear regression models

Results The median age of 85 participants was 287 days B-Al (median 154 ngmL range 09ndash952 ngmL) and H-Al (median 42542 ngg range 2758ndash211690 ngg) were weakly correlated (Spearman ρ = 026 P = 03) There was no significant correlation between B-Al or H-Al and estimated aluminum load from vaccines B-Al was not correlated with BSID composite or subscale scores Although H-Al was notcorrelated with BSID scores in models including all data (n = 85) it was inversely correlated with motor composite (P lt 02 Wald = 588) and the gross motor subscale (P = 04 Wald = 438) in models that excluded an extreme outlying H-Al value

Conclusions Infant B-Al and H-Al varied considerably but did not correlate with their immunization history Likewise there was no correlation between B-Al and infant development or between H-Al and language or cognitive development An inverse correlation between H-Al and BSID motor scores deserves further investigation

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 48: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

The Vaccine Page httpswwwfacebookcomthevaccinepage

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 49: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

UPDATED ALUMINUM PHARMACOKINETICS FOLLOWING INFANT EXPOSURES THROUGH DIET AND VACCINATION

Mitkus RJ1 King DB Hess MA Forshee RAWalderhaug MO

Aluminum is a ubiquitous element that is released naturally into the environment via volcanic activity and the breakdown of rocks on the earths surface Exposure of the general population to aluminum occurs primarily through the consumption of food antacids and buffered analgesics Exposure to aluminum in the general population can also occur through vaccination since vaccines often contain aluminum salts (frequently aluminum hydroxide or aluminum phosphate) as adjuvants Because concerns have been expressed by the public that aluminum in vaccines may pose a risk to infants we developed an up-to-date analysis of the safety of aluminum adjuvants Keith et al [1] previously analyzed the pharmacokinetics of aluminum for infant dietary and vaccine exposures and compared the resulting body burdens to those based on the minimal risk levels (MRLs) established by the Agency for Toxic Substances and Disease Registry We updated the analysis of Keith et al [1] with a current pediatric vaccination schedule [2] baseline aluminum levels at birth an aluminum retention function that reflects changing glomerular filtration rates in infants an adjustment for the kinetics of aluminum efflux at the site of injection contemporaneous MRLs and the most recent infant body weight data for children 0-60 months of age [3] Using these updated parameters we found that the body burden of aluminum from vaccines and diet throughout an infants first

year of life is significantly less than the corresponding safe body burden of aluminum modeled using the regulatory MRL We conclude that episodic exposures to vaccines that contain aluminum adjuvant continue to be extremely low risk to infants and that the benefits of using vaccines containing aluminum adjuvant outweigh any theoretical concerns

Vaccine 2011 Nov 2829(51)9538-43 doi 101016jvaccine201109124 Epub 2011 Oct 11

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 50: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

OVERALL SCHEDULE SAFETY

Question Is it true vaccines are only studied individually

Answer No Vaccines are tested against the other vaccines typically given that day You can find this information in the MMWR

ldquoVaccine administration Pneumococcal [polysaccharide] vaccine may be administered at the same time as influenza vaccine (by separate injection in the other arm) without an increase in side effects or decreased antibody response to either vaccine (6284) Pneumococcal vaccine also may be administered concurrently with other vaccines The administration of pneumococcal vaccine with combined diphtheria tetanus and pertussis (DTP) poliovirus or other vaccines does not increase the severity of reactions or diminish antibody responses (85)rdquo (MMWR April 04 1997 46(RR-08)1-24)

ldquoVaccine Administration PCV13 has been administered concurrently with vaccines containing the following antigens with no adverse effects on immunogenicity or safety diphtheria tetanus acellular pertussis Haemophilus influenzae type b inactivated poliomyelitis rotavirus hepatitis B meningococcal serogroup C measles mumps rubella and varicella (9) PCV13 can be administered at the same time as other routine childhood vaccinations if administered in a separate syringe at a separate injection site The safety and efficacy of concurrent administration of PCV13 and PPV23 has not been studied and concurrent administration is not recommendedrdquo (MMWR December 10 2010 59(RR11)1-18)

IOM study - ldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter1

Presenter
Presentation Notes
IOM stuldquoThe Childhood Immunization Schedule and Safetyrdquo httpwwwnapeduread13563chapter113

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 51: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

DO MULTIPLE VACCINES OVERWHELM OR WEAKEN THE INFANTrsquoS IMMUNE SYSTEM

bull Recent surveys found that an increasing number of parents are concerned that infants receive too many vaccines Implicit in this concern is that the infantrsquos immune system is inadequately developed to handle vaccines safely or that multiple vaccines may overwhelm the immune system In this review we will examine the following 1) the ontogeny of the active immune response and the ability of neonates and young infants to respond to vaccines 2) the theoretic capacity of an infantrsquos immune system 3) data that demonstrate that mild or moderate illness does not interfere with an infantrsquos ability to generate protective immune responses to vaccines 4) how infants respond to vaccines given in combination compared with the same vaccines given separately 5) data showing that vaccinated children are not more likely to develop infections with other pathogens than unvaccinated children and 6) the fact that infants actually encounter fewer antigens in vaccines today than they did 40 or 100 years ago

Offit PA Quarles J Gerber MA et al Addressing Parentsrsquo Concerns Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System Pediatrics 2002109(1)124ndash9

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 52: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

WHY VACCINATE ON TIME

bull Gets baby protected as soon as possible

bull Preparing not reacting

bull Keeps medical costs down by not adding extra check ups

bull Some vaccines canrsquot be given after a certain age

bull Doses donrsquot get lost

bull Donrsquot need a pile of ldquocatch uprdquo doses before entering school

bull Catching up is complicated

Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 53: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD
Presenter
Presentation Notes
Timing must be correct in terms of age length of time between each dose length of time from first dose to last dose timing relative to other vaccines (live vaccines must be on the same day or 28+ days apart)hellip

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 54: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

INDIVIDUALIZATION IN DOSING

bull ldquoWhy does my little baby get the same dose as an adult The dose is different for medications why not for vaccinesrdquo

bull Vaccine dosing is different than medication dosing

bull Vaccine doses donrsquot need to reach all the tissues of the body

bull They need to properly encounter immune cells which are located throughout the body

bull Immune cells are educated near where the vaccine is given then those immune cells travel throughout the body

bull Therefore we need only tiny quantities of vaccine and donrsquot generally need more or less for bigger or smaller bodies

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 55: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

INDIVIDUALIZATION IN SCHEDULING

bull Schedule ndash there is a myth that the vaccine schedule is ldquoone size fits allrdquo and thus providers should change the schedule to suit individual patients

bull The Contraindications and Precautions table lists contraindications and precautions for each vaccine (who should NOT get vaccine)

bull httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

bull Family history of autoimmunity is not a contraindication

bull Some medical conditions warrant ADDITIONAL vaccines

bull Most premature babies can receive vaccines on time for chronological age (donrsquot need to wait for adjusted age)

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 56: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

WHO SHOULD RECEIVE EXTRA VACCINE

bull Certain people are at higher risk for certain conditions

bull Some examples

bull Some premature babies are at higher risk of RSV and receive RSV immunoglobulin (passive immunization)

bull People with no spleen or no splenic function (eg sickle cell) are at higher risk for meningococcal pneumococcal Hib and receive additional early extra or special vaccines for those diseases

bull Other examples of high risk conditions cochlear implants HIV immune deficiencies stem cell transplant recipients chronic lung disease (incl severe asthma) CCHD diabetes renal disease cancers hellip see schedule footnotes

bull For adults with special conditions (including pregnancy) therersquos a special chart of recommended immunizations

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 57: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

Excerpt from httpswwwcdcgovvaccineshcpacip-recsgeneral-recscontraindicationshtml

Vaccine - Citation ndash Contraindication -- Precaution

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 58: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

MULTIPLE PERSPECTIVES ON MULTIPLE VACCINES

Presenter
Presentation Notes
Left httpwwweirenehealthshopcoza_Media293832_10150959853882989_medjpeg 13Right Plain Talk about Childhood Immunizations 2013 ndash this is a chart from 2000 and doesnrsquot include flu or rotavirus (5 antigens)13Even though the number of diseases we can prevent with vaccines has increased dramatically the number of antigens it takes to get there is somewhat reduced Our technology and ability to isolate the important antigens has improved tremendously

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 59: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

ANTIGEN COUNTS

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 60: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

INOCULATION AGAINST MISINFORMATION

bull When you encounter a web series blog post salacious article Google it and the word ldquodebunkedrdquo

bull httpsthelogicofsciencecom20160823measles-is-not-better-than-autism-debunking-anti-vaccine-arguments

bull Vaxopediaorg

bull Think about other instances of the phenomenon ndash was there a big change in hygienesanitation in the 1990s when Hib meningitis was nearly eradicated Or was it the vaccine

bull How about chicken pox in 1995

bull How about rotavirus in 2006

bull Try to appreciate the large body of literature and not a single studyhellip

bull Learn about journal quality journal impact factors predatory journals

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 61: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

PACKAGE INSERTS

bull Legal documents not medical documents

bull List of potential adverse effects include everything that happened to anybody involved in the trial even if it was not causally related

bull Current as of the time of LICENSURE by the FDA

bull Generally updated only with NEGATIVE information eg black box warnings

bull httpsvaxopediaorg20170710how-to-read-a-package-insert-for-a-vaccine

bull If you are tempted to use a package insert for clinical information (other than how to reconstitute) use the MMWR instead

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 62: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

COINCIDENCE CONUNDRUM

bull Autism

bull SIDS

bull Autoimmunity

httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment

Presenter
Presentation Notes
httpsthelogicofsciencecom20160628why-are-there-so-many-reports-of-autism-following-vaccination-a-mathematical-assessment13

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 63: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

DELAYED IMMUNIZATION

bull No evidence to suggest improved outcomes with delayed vaccination

bull Some vaccines have more side effects if you give them later ndash eg risk of febrile seizures is higher among 16-24 month olds compared to on-time (12-15 months) (Rowhani-Rahbar et al 2013)

bull Hib and PCV schedules change depending on starting age ndash can potentially drop 1-2 doses

bull Rotavirus must be started by 14w6d and completed by 8m0d

bull Primary DTaP series must be completed by 7y if delayed beyond age 6 therersquos no opportunity to have a primary series against pertussis

bull Delaying schedules introduces risk without providing any known benefit

Presenter
Presentation Notes
Rowhani-Rahbar A Fireman B Lewis E et al Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children JAMA Pediatr 2013167(12)1111ndash7

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 64: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

SELECTIVE IMMUNIZATION

bull For as long as there has been the idea of vaccines there have been anti-vaccine sentiment of various sorts

bull Recent concerns have centered around ingredients additives preservatives autism and immune system overwhelm

Presenter
Presentation Notes
httpsvaxopediaorg20170604anti-vaccine-movement-timeline-and-history13httpswwwhistoryofvaccinesorgcontentarticleshistory-anti-vaccination-movements

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 65: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing pertussis felt remote

bull Families were deliberately skipping pertussis immunization and using DT and Td instead

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 66: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

PERTUSSIS OUTBREAK OF 2012

bull Red line in the top graph is lt patients 1 year old

bull Graph on the bottom is cases per monthndash by the end of the year therersquod been 5000+ cases

Presenter
Presentation Notes
Pertussis Surveillance httpwwwdohwagovPortals1DocumentsPubs348-254-PertussisUpdatepdf13Pertussis Epidemic mdash Washington 2012 httpwwwcdcgovmmwrpreviewmmwrhtmlmm6128a1htm

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 67: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

SELECTIVE IMMUNIZATION

bull We definitely know that some diseases are more common than others

bull But this varies depending on region and moment in time

bull In 2010 when Elias started practicing measles felt remotehellip

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 68: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

MEASLES RESURGENCE

bull 2008 Several outbreaks including three large outbreaks cases attributed to spread in communities with groups of unvaccinated people 2011 In 2011 more than 30 countries in the WHO European Region reported an increase in measles and France was experiencing a large outbreak Most of the cases that were brought to the US in 2011 came from France

bull WHO 26000 cases of measles in 36 European countries from January-October 2011 with more than 14000 of those in France Despite strong health systems Western European countries have reported 83 of these cases These outbreaks have caused nine deaths including six in France and 7288 hospitalizations

bull 2013 The US experienced 11 outbreaks in 2013 three of which had more than 20 cases including an outbreak with 58 cases

bull 2014 The US experienced 23 measles outbreaks in 2014 including one large outbreak of 383 cases occurring primarily among unvaccinated Amish communities in Ohio Many of the cases in the US in 2014 were associated with cases brought in from the Philippines which experienced a large measles outbreak

Presenter
Presentation Notes
httpwwweurowhointenmedia-centresectionspress-releases201112european-countries-must-take-action-now-to-prevent-continued-measles-outbreaks-in-2012httpwwwepicentroissitproblemimorbillobollettinoMeasles_WeeklyReport_N33engpdf132015 Washington Woman Is First US Measles Death in 12 Years Available from httpswwwnbcnewscomhealthhealth-newswoman-dies-measles-first-us-death-12-years-n38594613

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 69: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

MEASLES OUTBREAKS

bull 2015 Washington Woman Is First US Measles Death in 12 Years

bull 2015 The United States experienced a large multi-state measles outbreak linked to an amusement park in California The outbreak likely started from a traveler who became infected overseas with measles then visited the amusement park while infectious however no source was identified Analysis by CDC scientists showed that the measles virus type in this outbreak(B3) was identical to the virus type that caused the large measles outbreak in the Philippines in 2014

bull 2017 On April 10 2017 the Minnesota Department of Health (MDH) was notified about a suspected measles case The patient was a hospitalized child aged 25 months who was evaluated for fever and rash with onset on April 8 The child had no historyof receipt of measles-mumps-rubella (MMR) vaccine and no travel history or known exposure to measles In a community with previously high vaccination coverage concerns about autism the perceived increased rates of autism in the Somali-American community and the misunderstanding that autism was related to the measles-mumps-rubella (MMR) vaccine resulted in a decline in MMR vaccination coverage to a level low enough to sustain widespread measles transmission in the Somali-American community following introduction of the virus By May 31 2017 a total of 65 confirmed measles cases had been reported to MDH

bull 2018 At least 70 children dead in Venezuela measles outbreak

httpswwwcdcgovmeaslescases-outbreakshtml

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 70: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

EUROPE 2017

bull 2016 5273

bull 2017 21315

Italy Greece Romania France Germany Belgium Ukraine France Russia Tajikistan

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 71: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

FURTHER OUTBREAKS

bull ldquoHepatitis A Outbreaks Appearing Across the Nationrdquo ndash August 8 2017

bull httpswwwhhsgovhepatitisblog20170808hepatitis-a-outbreaks-appearing-across-the-countryhtml

bull Widespread mumps outbreaks

bull Return of diphtheria ldquothe strangling angel of childrenrdquo

bull httpappswhointimmunization_monitoringglobalsummarytimeseriestsincidencediphtheriahtml

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 72: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

ALTERNATIVE SCHEDULES

Can you identify where the child is left vulnerable

left vulnerable to bull Poliobull Hibbull Pneumococcalbull Rotavirusbull Hep Bbull Hep Abull Varicellabull Influenza

Presenter
Presentation Notes
PaleoMama left vulnerable to polio pneumococcal rotavirus hep B hep A varicella Hib flu1313

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 73: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

Can you identify where the child is left vulnerable

Presenter
Presentation Notes
Black and white hep B ndash no protection in infancy when child is most likely to end up with chronic hep B polio ndash no protection in early childhood varicella ndash no protection hep A ndash no protection rotavirus ndash no protection MCV ndash no protection 15 year old would receive Tdap not DTaP DTaP and Hib are significantly delayed leaving baby exposed or insufficiently protected for 3-5 months longer than usualMMR ndash transplacental protection would have waned far before 18 months Varicella ndash exposed through entirety of childhood13

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 74: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

ldquoVACCINE FRIENDLY PLANrdquo (THOMAS)

Can you identify where child is left vulnerable

bull Pertussis when most likely to die

bull Polio

bull Rotavirus

bull Hep B when serious complications most likely

bull Hep A

bull Varicella

bull Influenza

bull MTHFR family history autoimmunity autism are not contraindications for vaccines

bull No combo vaccines = more injections

bull More visits = more car trips more waiting room exposures

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 75: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen in 1 5 10 50 years

bull We donrsquot know whatrsquos coming into the countryregionareacounty

bull Vaccine shortages are common in an outbreak

bull It takes time and multiple doses to gain immunity

bull Some vaccines must be startedcompleted by a certain age or yoursquore no longer eligible

bull We donrsquot know when yoursquore going to step on a rusty nail hellip and need not just tetanus vaccine but also immunoglobulin which is a blood product

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 76: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

PREPARING VS REACTING

bull We donrsquot know whatrsquos going to happen to the patientrsquos family

bull New baby Preschooler with pertussis could be devastating to that 2-week-old

bull Economic disruption Can you afford a quarantine

bull Going to daycare Regulations plus new exposureshellip

bull Travel If yoursquore behind how many months and doses will it take to catch up plus the vaccines requiredrecommended for the travel region

bull New diagnosis Previously healthy kid now with lots of exposure to the healthcare system or previously healthy parent now with a cancer diagnosis

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 77: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

PREPARING VS REACTING

bull Babies grow into kids who grow into teens and young adults who make different decisions than you do

bull Riskier behavior than you think or know

bull College ndash many vaccines are required for college and there are new risks from dorm living

bull Pregnancy ndash what if shersquos not immune to rubella and her fetus develops congenital rubella syndrome

bull Travel ndash ldquoI want to travel with school I donrsquot like shots but I donrsquot want to die of some death disease eitherrdquo ndashunderimmunized 14-year-old patient explaining to his mother his desire to be immunized

bull Providers should continue to offer and recommend vaccines even for families refusing because their circumstances may have changed and everyone should have the chance to make a new decision

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 78: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

HPV A CASE IN PREPARATION

bull HPV 9-valent vaccine is estimated to preventbull 85 of cervical cancers

bull 70 of oropharyngeal cancers

bull 80 of anal cancers

bull 60 of penile cancersbull About 25K cancers in US each year prevented

bull A vaccine for cancer is a really incredible thing

bull High risk HPV causes 5 of all the worldrsquos cancer

bull You can prevent misery suffering and death

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 79: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

HPV IS DEADLY

bull Only some cancers can be screened for

bull Even if a cancer is caught early with a Pap smear the treatment has its own morbidity

bull Screening is not prevention

bull Immunization is prevention

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 80: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

HPV VACCINES ARE HIGHLY EFFECTIVE

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 81: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

HPV VACCINE IS SAFE

bull Placebo-controlled studies show that adverse events are primarily sore arms and sycope

bull No increase in auto-immune conditions (Grimaldi-Bensouda et al 2017)

bull Hundreds of studies covering millions of doses and millions of people consistently fail to identify any safety signals associated with HPV vaccines

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 82: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

HPV PREPARATION

bull Immunity must be in place beforeexposure

bull 80 of people will be exposed to HPV

bull HPV detected in 50 of women prior to first vaginal sex (Doerfler 2009)

bull You canrsquot predict who or when protect everyone

Presenter
Presentation Notes
Doerfler D Bernhaus A Kottmel A Sam C Koelle D Joura EA Human papilloma virus infection prior to coitarche American Journal of Obstetrics and Gynecology 2009200(5)487e1-487e513

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 83: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

MAKING A STRONG RECOMMENDATION

bull Make your recommendation

bull If there are questions or concerns try your best to respond

bull Make your recommendation again (Opel 2013)

bull Continue to be in relationship ndash you are available for continued conversation and will continue to make the recommendation

bull ldquoIrsquom not going to bully or force you but I am going to continue to talk about it with yourdquo

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 84: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

WHAT TO EXPECT AFTER IMMUNIZATIONS

bull Our goal is to induce an immune reaction

bull Mild adverse effects like fever fussiness redness are more common than serious side effects like seizures which are very rare

bull With live vaccines the adverse effects are typically a ldquominirdquo version of the disease (eg chicken pox-like rash)

bull With inactivated vaccines the adverse effects are typically local (redness tenderness at the injection site)

bull Each Vaccine Information Statement (VIS) reviews what to expect at what rate and when to contact your doctor -- httpimmunizeorgvis

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 85: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

PROTECTING THE HERD

bull Herd immunity is actually community immunity

bull If enough people are immune then a disease canrsquot reproduce and spread

bull Immunizing everyone who can be immunized helps to protect those who canrsquot be immunized either because theyrsquore too young or because they canrsquot receive the vaccine

bull Each disease has its own ldquocommunity immunity thresholdrdquo for how many people must be immune in order to stop transmission and prevent an outbreak

bull Note that measles and pertussis have the highest community immunity thresholds and these are the vaccine-preventable diseases that are starting to re-emerge as coverage rates have dropped

Presenter
Presentation Notes
The basic reproduction number is defined as the number of persons an infectious case coming into contact with a 100 susceptible population would transmit infection to on average

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 86: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

HERD IMMUNITY ANIMATION

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 87: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

CANrsquoT I JUST ____

bull Breastfeed ndash breastfeeding passes along certain antibodies (passive immunity) but they are generally not specific to the disease It is an excellent foundation of health

bull Breastfeeding also seems to yield a better immune response to certain vaccines (Hib and PCV)

bull Avoid sick people ndash most diseases are contagious for days before symptoms arise

bull Immunize specific populations (eg by population density socioeconomic status risk factors) ndash these approaches have been tried (eg early HBV programs influenza) and they are not as effective as broad community coverage

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 88: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

ANTIBODY SOURCES FOR INFANTS amp KIDS

Presenter
Presentation Notes
Courtesy NFID and Carol Baker MD13Purple line = antibodies the pregnant person made through vaccination or through prior infection (eg flu pertussis measles)13Blue line = antibodies through breastmilk13Yellow = antibodies the child is making himself first in response to vaccination then on his own if he doesnrsquot receive vaccinations

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 89: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

VACCINATIONS IN PREGNANCY

bull Influenza is dangerous to the pregnant person because of the unique load on the heart and lungs during pregnancy

bull Fever is bad for fetuses and depending on timing can cause malformations (including neural tube defects and clefts)

bull Influenza can additionally cause low birth weight and preterm birth

bull Influenza vaccine during pregnancy effectively reduces the risks for the pregnant person and the fetus

bull And additionally reduces the risk of hospital admission for respiratory illness in the first 6 months of life

Presenter
Presentation Notes
1 13Blanchard-Rohner G Siegrist C-A Vaccination during pregnancy to protect infants against influenza why and why not Vaccine 201129(43)7542-7550 doi101016jvaccine201108013132 13Nitsch-Osuch A Woźniak Kosek A Brydak LB [Vaccination against influenza in pregnant women - safety and effectiveness] Ginekol Pol 201384(1)56-61133 13Naleway AL Irving SA Henninger ML et al Safety of influenza vaccination during pregnancy A review of subsequent maternal obstetric events and findings from two recent cohort studies Vaccine 2014 doi101016jvaccine201404021134 13Rasmussen SA Jamieson DJ Uyeki TM Effects of influenza on pregnant women and infants American Journal of Obstetrics and Gynecology 2012207(3 Supplement)S3-S8 doi101016jajog20120606813

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 90: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

TDAP IN PREGNANCY

bull Pertussis (whooping cough) is not thought to be additionally dangerous for the pregnant person but is definitely inconvenient

bull Pertussis can be deadly for the newborn with most deaths happening in the first 3 months

bull Decision analysis model showed that Tdap vaccination during pregnancy would prevent more illness and deaths in newborns than a postpartum dose (6) so in 2012 ACIP recommended a dose of Tdap in each pregnancy

bull Ongoing surveillance shows highly effective prevention of severe pertussis in the baby with pregnancy immunization (78)

bull Immunization in the third trimester yields the highest antibody transfer to baby (4)

Presenter
Presentation Notes
Graphic httpwwwcdcgovvaccinespubspinkbookperthtml131 Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States April 2009--August 2010 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6035a2htm Accessed May 1 2014132 POEHLING KA SZILAGYI PG STAAT MA et al Impact of Maternal Immunization on Influenza Hospitalizations in Infants Am J Obstet Gynecol 2011204(6 Suppl 1)S141-S148 doi101016jajog201102042133 Omer SB Goodman D Steinhoff MC et al Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births A Retrospective Cohort Study PLoS Med 20118(5)e1000441 doi101371journalpmed1000441134 Healy CM Rench MA Baker CJ Importance of timing of maternal combined tetanus diphtheria and acellular pertussis (Tdap) immunization and protection of young infants Clin Infect Dis 201356(4)539-544 doi101093cidcis923135 Matlow JN Pupco A Bozzo P Koren G Tdap vaccination during pregnancy to reduce pertussis infection in young infants Can Fam Physician 201359(5)497-498136 Updated Recommendations for Use of Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women mdash Advisory Committee on Immunization Practices (ACIP) 2012 Available at httpwwwcdcgovmmwrpreviewmmwrhtmlmm6207a4htm Accessed May 1 2014137 Winter K Cherry JD Harriman K Effectiveness of prenatal Tdap vaccination on pertussis severity in infants Clin Infect Dis 2016ciw633 138 Skoff TH Blain AE Watt J et al Impact of the US Maternal Tetanus Diphtheria and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants lt2 Months of Age A Case-Control Evaluation Clin Infect Dis [Internet] [cited 2017 Sep 29]Available from httpsacademicoupcomcidarticledoi101093cidcix7244237166Impact-of-the-US-Maternal-Tetanus-Diphtheria-and13

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 91: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

PREGNANCY TDAP IS HIGHLY EFFECTIVE

bull Vaccine effectiveness vs lab confirmed pertussis in babies under 3 months 91 (95 CI 84 to 95) (Amirthalingam 2014)

bull Vaccine effectiveness in babies under 8 weeks 93 (Dabrera 2015)

bull Vaccine effectiveness against laboratory-confirmed pertussis has been sustained gt90 in the 3 years following its introduction (Amirthalingam 2016)

bull Vaccine effectiveness against infant deaths was estimated at 95 (95 confidence interval 79ndash100) (Amirthalingam 2016)

Presenter
Presentation Notes
Amirthalingam G Andrews N Campbell H et al Effectiveness of maternal pertussis vaccination in England an observational study Lancet 2014384(9953)1521ndash813Dabrera G Amirthalingam G Andrews N et al A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales 2012-2013 Clin Infect Dis 201560(3)333ndash713Amirthalingam G Campbell H Ribeiro S et al Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction Clin Infect Dis 201663(Suppl 4)S236ndash43

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 92: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

SAFETY OF PERTUSSISVACCINATION IN PREGNANT WOMEN IN UKOBJECTIVE To examine the safety of pertussis vaccination in pregnancy

DESIGN Observational cohort study

SETTING The UK Clinical Practice Research Datalink

PARTICIPANTS 20074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group

MAIN OUTCOME MEASURE Adverse events identified from clinical diagnoses during pregnancy with additional data from the matched child record identified through mother-child linkage The primary event of interest was stillbirth (intrauterine death after 24 weeks gestation)

RESULTS There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 069 95 confidence interval 023 to 162) or later in pregnancy (085 044 to 161) compared with historical national rates Compared with a matched historical cohort of unvaccinated pregnant women there was no evidence that vaccination accelerated the time to delivery (hazard ratio 100 097 to 102) Furthermore there was no evidence of an increased risk of stillbirth maternal or neonatal death pre-eclampsia or eclampsia haemorrhage fetal distress uterine rupture placenta or vasa praevia caesarean delivery low birth weight or neonatal renal failure all serious events that can occur naturally in pregnancy

CONCLUSION In women given pertussis vaccination in the third trimester there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy In particular there was no evidence of an increased risk of stillbirth Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making

Donegan K King B Bryan P Safety of pertussis vaccination in pregnant women in UK observational study BMJ 2014349g4219

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 93: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

INFANT HOSPITALIZATIONS AND MORTALITY AFTER MATERNAL VACCINATIONBACKGROUND The Advisory Committee on Immunization Practices currently recommends pregnant women receive influenza and tetanus toxoid reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines There are limited studies of the long-term safety in infants for vaccines administered during pregnancy We evaluate whether maternal receipt of influenza and Tdap vaccines increases the risk of infant hospitalization or death in the first 6 months of life

METHODS We included singleton live birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 Outcomes were infant hospitalizations and mortality in the first 6 months of life We performed a case-control study matching case patients and controls 11 and used conditional logistic regression to estimate odds ratios for maternal exposure to influenza andor Tdap vaccines in pregnancy

RESULTS There were 413 034 live births in our population Of these 25 222 infants had hospitalizations and 157 infants died in the first 6 months of life We found no association between infant hospitalization and maternal influenza (adjusted odds ratio 100 95 confidence interval [CI] 096ndash104) or Tdap (adjusted odds ratio 094 95 CI 088ndash101) vaccinations We found no association between infant mortality and maternal influenza (adjusted odds ratio 096 95 CI 054ndash169) or Tdap (adjusted odds ratio 044 95 CI 017ndash113) vaccinations

CONCLUSIONS We found no association between vaccination during pregnancy and risk of infant hospitalization or death in the first 6 months of life These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy

Sukumaran L McCarthy NL Kharbanda EO et al Infant Hospitalizations and Mortality After Maternal Vaccination Pediatrics 2018

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources
Page 94: BUILDING A FOUNDATION OF IMMUNITY · • Many concerns about vaccines are based on biochemical pathways or mechanism • Don’t stop there! ... doses) were administered in the VSD

RESOURCES

bull httpwwwNDsforVaccinesorg - NDs writing in support of immunizations

bull httpwwwvaxopediaorg - A Texas pediatrician who writes many short articles addressing vaccine myths concepts evidence

bull httpwwwvaxnorthwestorg - regional parents talking about the importance of vaccination

bull httpwwwimmunizeorg -- extensive resource for disease and vaccine information for HCPs and parents including specific sections targeting questions around alternative schedules autism mercury etc

bull httpwwwcdcgovvaccinesscheduleshcpchild-adolescenthtml -- schedules and catch up schedules

bull httpwwwsoundsofpertussiscom -- outreach site around pertussis

bull httpwwwcdcgovvaccinesvac-gen6mishomehtm - Top 6 Misconceptions

bull httpwwwkingcountygovdeptshealthcommunicable-diseasesimmunizationchildplain-talk-about-childhood-immunizationsaspx ldquoPlain Talk about Childhood Immunizationsrdquo -- fantastic book that addresses just about any question a family might have about vaccines Download in multiple languages

bull httpwwwchopeduservicevaccine-education-centerhomehtml -- Childrenrsquos Hospital of Philadelphia Vaccine Education Center ndash excellent parent-focused information about vaccines and vaccine-preventable disease including an app called Vaccines on the Go

  • Building a Foundation of Immunity
  • DISCLOSURES
  • Disclosures and obtaining Continuing medical education credit
  • Slide Number 4
  • Background
  • Vaccines are naturopathic
  • We still need vaccines
  • Universal Diseases
  • Measles a case study
  • Morbidity vs Mortality
  • Mortality vs Cases
  • Simple rash
  • Vaccinersquos continued contribution
  • Slide Number 14
  • Pros and Cons of Natural Infection
  • Immunosuppression
  • Non-Specific Effects of Measles and other vaccines
  • Concern Th1 vs Th2
  • Vaccines do not cause allergies
  • Slide Number 20
  • Concern vs Actual Effect
  • MechanismPathway vs Actual Effect
  • Concern varicella vs zoster
  • Safety Monitoring
  • Safety Monitoring VAERS
  • Safety Monitoring Vaccine Safety Datalink (VSD)
  • Vaccine safety case Rotavirus
  • Vaccine safety case Rotavirus
  • VSD Rotavirus (2014)
  • Rotavirus why bother
  • Efficacy case LAIV (Flumist)
  • Who is ACIP
  • ACIP - Schedule
  • Slide Number 34
  • Walking through the Childhood Schedule
  • Types of Vaccines
  • Vaccines Prevent Disease
  • Why should we even prevent disease
  • Slide Number 39
  • Slide Number 40
  • Slide Number 41
  • Hep B why
  • Hep B Starts at Birth
  • The Power of Hepatitis B
  • Prevention
  • Infants Do Have Immune Systems
  • Aluminum
  • Aluminum in TPN
  • Does aluminum bioaccumulate Is it correlated with developmental disability
  • Slide Number 50
  • Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
  • Overall Schedule Safety
  • Do Multiple Vaccines Overwhelm or Weaken the Infantrsquos Immune System
  • Why Vaccinate on Time
  • Slide Number 55
  • Individualization in Dosing
  • Individualization in Scheduling
  • Who Should Receive Extra Vaccine
  • Slide Number 59
  • Slide Number 60
  • Multiple Perspectives on Multiple Vaccines
  • Slide Number 62
  • Antigen Counts
  • Inoculation against misinformation
  • Package inserts
  • Coincidence conundrum
  • Delayed Immunization
  • Selective Immunization
  • Selective Immunization
  • Pertussis Outbreak of 2012
  • Selective Immunization
  • Measles resurgence
  • Measles Outbreaks
  • Europe 2017
  • Further outbreaks
  • Alternative Schedules
  • Slide Number 77
  • ldquoVaccine Friendly Planrdquo (Thomas)
  • Preparing vs Reacting
  • Preparing vs Reacting
  • Preparing vs Reacting
  • HPV a case in preparation
  • HPV is deadly
  • HPV Vaccines are highly effective
  • HPV Vaccine is Safe
  • HPV Preparation
  • Making a strong recommendation
  • What to Expect after Immunizations
  • Protecting the Herd
  • Herd Immunity Animation
  • Canrsquot I Just ____
  • Antibody Sources for Infants amp Kids
  • Vaccinations in Pregnancy
  • Tdap in Pregnancy
  • Pregnancy Tdap is Highly Effective
  • Safety of pertussis vaccination in pregnant women in UK
  • Infant Hospitalizations and Mortality After Maternal Vaccination
  • Resources